Back to all papers

Pooled two-cohort MRI body composition phenotyping with open-source deep learning.

August 29, 2026pubmed logopapers

Authors

Mertens CJ,Häntze H,Ziegelmayer S,Kather JN,Truhn D,Kim SH,Busch F,Weller D,Wiestler B,Graf M,Bamberg F,Schlett CL,Weiss JB,Ringhof S,Can E,Schulz-Menger J,Niendorf T,Lammert J,Molwitz I,Kader A,Hering A,Meddeb A,Nawabi J,Schulze MB,Keil T,Willich SN,Krist L,Hadamitzky M,Hannemann A,Bassermann F,Rueckert D,Pischon T,Hapfelmeier A,Makowski MR,Bressem KK,Adams LC

Affiliations (32)

  • Institute for Diagnostic and Interventional Radiology, School of Medicine and Health, TUM Klinikum, Technical University of Munich (TUM), Munich, Germany.
  • Diagnostic Image Analysis Group, Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Else Kroener Fresenius Center for Digital Health, Dresden University of Technology, Dresden, Germany.
  • Department of Medicine I, University Hospital Dresden, Dresden, Germany.
  • Medical Oncology, National Center for Tumour Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
  • Department for Diagnostic and Interventional Radiology, University Hospital Aachen, Aachen, Germany.
  • Department of Diagnostic and Interventional Neuroradiology, School of Medicine and Health, TUM Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
  • Department of Diagnostic and Interventional Radiology, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
  • Charité, Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, ECRC Experimental and Clinical Research Center, Berlin, Germany.
  • Working Group on CMR, Experimental and Clinical Research Center, a Joint Cooperation Between the Max-Delbrück-Center for Molecular Medicine and the Charité, Universitätsmedizin Berlin, Berlin, Germany.
  • DZHK (German Centre for Cardiovascular Research), Berlin, Germany.
  • Department of Cardiology and Nephrology, Helios Hospital Berlin-Buch, Berlin, Germany.
  • Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Ultrahigh Field Facility (B.U.F.F.), Berlin, Germany.
  • Experimental and Clinical Research Center (ECRC), Charité-Universitätsmedizin Berlin, A Joint Cooperation Between the Charité Medical Faculty and the Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
  • Department of Gynecology and Center for Hereditary Breast and Ovarian Cancer, Technical University of Munich (TUM), School of Medicine and Health, Klinikum rechts der Isar, TUM University Hospital, Munich, Germany.
  • Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Neuroradiology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany.
  • Institute of Nutrition Science, University of Potsdam, Nuthetal, Germany.
  • Institute of Social Medicine, Epidemiology and Health Economics, Charité, Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Department of Cardiovascular Radiology and Nuclear Medicine, German Heart Center Munich, TUM University Hospital, Munich, Germany.
  • Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany.
  • Department of Medicine III, Technical University of Munich, TUM School of Medicine and Health, Munich, Germany.
  • Center for Translational Cancer Research (TranslaTUM), Technical University of Munich, TUM School of Medicine and Health, Munich, Germany.
  • Munich Center for Machine Learning (MCML), Munich, Germany.
  • Chair of AI in Healthcare and Medicine, Technical University of Munich (TUM) and TUM University Hospital, Munich, Germany.
  • Department of Computing, Imperial College London, London, UK.
  • Molecular Epidemiology Research Group, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
  • Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biobank Technology Platform, Berlin, Germany.
  • Charité, Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Technische Universität of Munich, School of Medicine and Health, TUM University Hospital Rechts der Isar, Institute of AI and Informatics in Medicine and Institute of General Practice and Health Services Research, Munich, Germany.
  • Institute for Diagnostic and Interventional Radiology, School of Medicine and Health, TUM Klinikum, Technical University of Munich (TUM), Munich, Germany. [email protected].

Abstract

Body mass index fails to capture variation in fat and muscle distribution that determines metabolic health and disease risk. MRI enables radiation-free quantification of regional body composition, yet scalable open-source tools applied in pooled cohorts with differing acquisition protocols have been lacking. MRSegmentator, an open-source nnU-Net-based pipeline, was applied to quantify visceral adipose tissue (VAT), abdominal subcutaneous adipose tissue (ASAT), gluteofemoral adipose tissue (GFAT), trunk musculature, and the liver mask used for liver fat-fraction estimation in 45,851 adults from the German National Cohort (n = 26,877, 3 T multi-centre Siemens) and UK Biobank (n = 18,974, 1.5 T Siemens). Population-scale compartment volumes were segmented from stitched in-phase gradient-echo (GRE) images in both cohorts; liver fat fraction was calculated from fat-only and water-only images. The annotated development data comprised NAKO T2-HASTE and UKB Dixon reconstructions. A single pooled model was applied without site-specific adaptation. A separate two-reader agreement study used 50 scans from these annotated development-sequence domains. Associations between BMI-adjusted body composition and cardiometabolic conditions were estimated using generalized linear mixed-effects models. Incremental discrimination beyond age, BMI, and waist-to-hip ratio was assessed. Five-fold participant-stratified internal cross-validation against curated human-in-the-loop development references comprising UKB Dixon and NAKO T2-HASTE yielded a mean Dice of 0.91. In a separate 50-scan reader study on these annotated development-sequence images, overall reader-reader Dice was 0.937 and overall algorithm-reader Dice was 0.908. The trained pipeline was then used to segment compartment volumes from stitched in-phase GRE inputs in both cohorts, while liver fat fraction was calculated from fat-only and water-only images; direct sequence-matched validation on NAKO GRE was not performed. VAT showed the strongest positive associations with cardiometabolic conditions, while GFAT showed inverse associations, most prominently for type 2 diabetes (OR 0.69, 95% CI 0.66 to 0.72). Disease-specific body-composition phenotypes were identified, with type 2 diabetes characterized by elevated VAT, reduced GFAT, and increased liver fat. MRI-derived compartments modestly improved discrimination for type 2 diabetes and hyperlipidemia beyond anthropometric measures. A single open-source deep-learning pipeline enabled pooled body-composition phenotyping in two cohorts and captured distributional variation in fat and muscle beyond BMI. High agreement in internal cross-validation (mean Dice 0.91) and the separate two-reader study support the annotated development-sequence analysis, while the population-scale application identified distinct disease-associated phenotypes and modest incremental discrimination beyond conventional anthropometry.

Topics

Journal Article

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.